Ryan Bremseth-Vining, MS
VISN 4 Mental Illness Research, Education, and Clinical Center (MIRECC), Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania
Original Research
GLP-1 Receptor Agonists and Overdose Risk in Veterans with Type 2 Diabetes and Opioid Use Disorder
July 15, 2026
Semaglutide and tirzepatide were associated with lower risk of all-cause overdose compared to insulin and SGLT2i inhibitors, but not metformin, sulfonylureas, or DPP4 inhibitors.
